Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 15;15(6):e40463.
doi: 10.7759/cureus.40463. eCollection 2023 Jun.

The Role of Sirtuin 1 (SIRT1) in Neurodegeneration

Affiliations
Review

The Role of Sirtuin 1 (SIRT1) in Neurodegeneration

Daniel I Razick et al. Cureus. .

Abstract

Sirtuins (SIRT) are a class of histone deacetylases that regulate important metabolic pathways and play a role in several disease processes. Of the seven mammalian homologs currently identified, sirtuin 1 (SIRT1) is the best understood and most studied. It has been associated with several neurodegenerative diseases and cancers. As such, it has been further investigated as a therapeutic target in the treatment of disorders such as Parkinson's disease (PD), Huntington's disease (HD), and Alzheimer's disease (AD). SIRT1 deacetylates histones such as H1 lysine 26, H3 lysine 9, H3 lysine 56, and H4 lysine 16 to regulate chromatin remodeling and gene transcription. The homolog has also been observed to express contradictory responses to tumor suppression and tumor promotion. Studies have shown that SIRT1 may have anti-inflammatory properties by inhibiting the effects of NF-κB, as well as stimulating upregulation of autophagy. The SIRT1 activators resveratrol and cilostazol have been shown to improve Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) scores in AD patients. In this review, we aim to explore the various roles of SIRT1 with regard to neuroprotection and neurodegeneration.

Keywords: alzheimer's disease; histone deacetylase (hdac); neurodegeneration; neurological diseases; sirtuin 1.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Small molecules as SIRT modulators. Bai X, Yao L, Ma X, Xu X. Mini Rev Med Chem. 2018;18:1151–1157. - PubMed
    1. Sirtuins as regulators of metabolism and healthspan. Houtkooper RH, Pirinen E, Auwerx J. Nat Rev Mol Cell Biol. 2012;13:225–238. - PMC - PubMed
    1. Mitochondrial sirtuins. Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E. Biochim Biophys Acta. 2010;1804:1645–1651. - PubMed
    1. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Vaquero A, Scher MB, Lee DH, et al. Genes Dev. 2006;20:1256–1261. - PMC - PubMed
    1. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD. Du J, Jiang H, Lin H. Biochemistry. 2009;48:2878–2890. - PubMed

LinkOut - more resources